1. FDA. (2002).Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach.
2. FDA. (2004).Guidance for Industry: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance.
3. Griffiths, W. (2003). Bayesian inference in the seemingly unrelated regressions model.Computer-Aided Econometrics, eds. D. E. A. Giles, New York, Marcel Dekker, 263–290.
4. ICH. (2005).ICH Harmonized Tripartite Guideline: Quality Risk Management, Q9.
5. ICH. (2007).ICH Harmonized Tripartite Guideline: Pharmaceutical Development, Q8.